Anticavity toothpaste recalled due to manufacturing practice deviations
Anticavity toothpaste containing sodium fluoride is being recalled due to manufacturing deviations. The recall affects 391,680 tubes distributed in Delaware and North Carolina.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary Class II recall with no reported illnesses or injuries. The hazard consists of manufacturing deviations without identified contamination or health impact, making it a precautionary recall.
Plain-English summary
Maximum Security Anticavity Gel Toothpaste (0.22% sodium fluoride, 17g tubes) is being recalled due to deviations from Good Manufacturing Practices (CGMP). The recall affects 391,680 tubes that were distributed in Delaware and North Carolina.
The manufacturer, KENIL HEALTHCARE PRIVATE LIMITED, initiated this voluntary recall on April 24, 2025. The product is identified by NDC 53247-132-02 and includes multiple lot numbers with expiration dates ranging from May to August 2026.
The recalled product
- Product
- Maximum Security Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, Net Wt 0.6 OZ (17 g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-02
- Manufacturer
- KENIL HEALTHCARE PRIVATE LIMITED
- Category
- Drug — Toothpaste
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lot B0009
- B0017
- Exp Date: 05/31/2026
- Lot B0018
- B0019
- B0036
- B0037
- B0038
- Exp Date: 06/30/2026
- Lot B0049
- Exp Date: 07/31/2026
- B0063
- Exp Date: 08/31/2026
Distribution
Distributed in 2 states:
- DE
- NC
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27